Kimialys recognized in Challenges’ top 100 startups list for 2023
news

Kimialys recognized in Challenges’ top 100 startups list for 2023

14/2/2024

By Cyril Gilbert

1 min read

We are thrilled to announce that Kimialys is part of Challenges' Challenges’ prestigious “Top 100 Startups Where to Invest” 2023 list.

This recognition highlights our team’s dedication to advance innovative diagnostic tests and support pharmaceutical companies in their drug development efforts. This achievement sets Kimialys as one of the most promising startups in its field, meeting the needs of the fast-growing in vitro diagnostic and biopharmaceutical industries.

For further information and to watch the 3 minute pitch of our CEO, Cyril Gilbert:

Subscribe to our newsletter!

Subscribe to our monthly newsletter and stay informed about the latest news, application notes, and insights from our activities.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By clicking on "Accept all cookies", you agree to the storage of cookies on your device to improve site navigation, analyze site usage and assist us in our marketing efforts. See our Cookie policy for more information.